Drug Trial Radar · NCT05736107
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Last checked: Nov 19, 2026Latest source record: Jul 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
107
Actual
Start
May 30, 2023
Primary completion
May 20, 2024
Study completion May 20, 2024
Sponsor
- Lead sponsor
- Caliway Biopharmaceuticals Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, placebo-controlled, Phase 2b study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing subcutaneous fat.
Conditions
- Subcutaneous Fat
Interventions
CBL-514 InjectionDrug
Formulated as an injectable CBL-514 solution at a concentration of 5 mg/mL.
0.9% Sodium ChlorideOther
Sodium Chloride (0.9% NaCl) placebo for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participants with at least 1-grade improvement reported by Investigator using the Clinician-Reported Abdominal Fat Rating ScaleTime frame: From baseline to 12 weeks after the final treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Investigational site 1
Pflugerville, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.